Associate Timothy Slattery (Antitrust-Washington, DC) has contributed to the Pharmaceutical Industry Antitrust Handbook (2nd Ed.) published by the American Bar Association. Tim was Editor and Contributing Author to Chapter II "Regulatory and Enforcement Framework" of the book.
The chapter covers subjects such as FDA drug approval requirements, The Hatch-Waxman Act, government antitrust enforcement, private suits and class actions relating to reverse payment settlements, and government price regulation.
Purchase the Pharmaceutical Industry Antitrust Handbook.
The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.
